RxDoctor Payments Data

Aaron Murfin, APRN

Family · Lancaster, OHNPI 1821646092

Payments from drug & device makers

$2,180in general payments, 2019–2025

Across 128 payments — averaging $17.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$516
  • Astellas Pharma US Inc$167
  • Pfizer$147
  • AstraZeneca$133
  • Novartis$100
  • Dexcom, Inc.$98
  • plus $1K from 21 others

What the payments were for

  • Food & beverage$2,08296%
  • Education$984%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,180 in reported general payments places this provider in the 80th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$14,357
Medicare patients
98
Services billed
118

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide27$47,966
EliquisApixaban14$18,651
NuedextaDextromethorphan Hbr/Quinidine12$18,639
JardianceEmpagliflozin11$18,446
FarxigaDapagliflozin Propanediol21$17,224
TrulicityDulaglutide14$16,923
Aimovig AutoinjectorErenumab-Aooe19$15,266
Breztri AerosphereBudesonide/Glycopyr/Formoterol22$13,421
Trelegy ElliptaFluticasone/Umeclidin/Vilanter16$11,263
Nurtec OdtRimegepant Sulfate11$11,021
Lacosamide32$4,655
Memantine Hcl110$3,090
Risperidone OdtRisperidone12$2,547
Gabapentin133$2,076
Aripiprazole15$1,589

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Breztri Aerosphere$133$30,64543 claims
PfizerEliquis, Nurtec Odt$147$29,67225 claims
Boehringer IngelheimJardiance$62$18,44611 claims
Lilly USA, LLCTrulicity$86$16,92314 claims
GSKTrelegy Ellipta$73$11,26316 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 6,812 family providers in Ohio.

Other family in Lancaster

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →